Quality Of Life Assessment In Alzheimer's Disease (AD) Patients Receiving Aricept Tablets (QUEST)

Pfizer

Status: Completed

Conditions: Alzheimer Disease

Treatments: Other: No intervention

Study type: Observational

Funder types: Industry

Identifiers

NCT01089582

A2501054

Details and patient eligibility

About

This study assessed the Hr QoL (Health related Quality of life) of subjects with mild to moderate AD, who received ARICEPT under usual clinical practice.

Full description

This non-interventional study enrolled patients with mild to moderate dementia of the Alzheimer's type, who have been prescribed treatment with ARICEPT under usual clinical practice.

Enrollment: 628 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Diagnosis of Alzheimer's Disease

Exclusion criteria

• There are no exclusion criteria

Trial design

628 participants in 1 patient group

AD patients

Treatment:

Other: No intervention